Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Newly Available on-demand webinar!

How to quantify AAV particle production from transfected HEK cells

Join ExcellGene SA, a company providing AAV production processes and develops such processes for its clients, in a free webinar. Dr. Yoann Saucereau, a research associate at ExcellGene, will discuss a fast and dependable method to assess the quantity and quality of particles during various stages of Adeno-Associated Virus (AAV) production.

Dr. Saucereau will delve into their robust and efficient approach for evaluating titers and ensuring the utmost quality of AAV viral particles throughout the production process.

Discover how ExcellGene’s scientists effectively addressed matrix effects in complex biological samples and established a quick and easily implementable routine for high-throughput and automated analysis of up to 96 samples in less than 30 minutes.

This innovative approach has greatly contributed to the development and manufacturing of AAV, streamlining quality control workflows.

The best part is that this invaluable knowledge is just a click away, and it’s completely free. Don’t hesitate any longer—access the webinar right now!

Learn about our AAV process development approaches and the use of clonally derived HEKzeroT® cell line which exhibits exceptional phenotypic characteristics in terms of robust growth, high transfectability, and the highest productivity of AAV virus-like particles.

Interested to know more? Contact our team now!

Yoann Saucereau, PhD.

Yoann Saucereau, PhD.

Research Associate Analytics

Webinar: Accelerate Assay Development and Reduce Cycle Times for AAV Quantification in Complex Biological Samples

Acknowledgement

Thank you, SARTORIUS and Pharma Focus Group!

We would like to express our appreciation to both teams for their collaboration and support in making this webinar possible.

For more information regarding the webinar, please visit: https://www.pharmafocuseurope.com/sartorius-aav-quantification-assay-development 

or, contact us directly.